BDNF and stroke disorder: Indeed, preclinical research suggests that multiple actions of NSCs offer great promise in treating the chronic phase of stroke through multiple mechanisms, including enhancement of neurogenesis and angiogenesis, mediated at least in part by paracrine signaling through growth factors and neurotrophins.